Quick Answer
LB PHARMACEUTICALS INC reported Diluted EPS of $3.13 per share (loss) for fiscal year 2025.
LB PHARMACEUTICALS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$3.13 | +98.2% |
| 2024 | -$176.15 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.61 | +98.5% | +98.5% |
| September 30, 2024 | -$39.49 | — | — |
- LB PHARMACEUTICALS INC showed an increase of +98.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2024–2025 period, LB PHARMACEUTICALS INC’s diluted eps has grown by 98.2% (from $176.15 per share (loss) to $3.13 per share (loss)).
- The most recent figure is from LB PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: